adecatumumab (MT201) - Amgen
Sandostatin LAR Depot (octreotide acetate) - Novartis
Somatuline Depot (lanreotide prolonged-release subcutaneous) - Ipsen, Teijin
octreotide sustained release (MTD201) - Midatech
http://www.abstractsonline.com/pp8/#!/5752/presentation/18746
 
Paul Seaman, PhD1; Stephen Damment, PhD1; Katherine Bamsey, BSc1; Anna Dryja, MD2; Craig Cook, MD1.
 
Apr 2, 2019
 
Prev Next